Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006

Emerging Infectious Diseases

Volumn 17, Issue 4, 2011, Pages 661-667

  Yung, Chee Fu ^a   Andrews, Nick ^a   Bukasa, Antoaneta ^a   Brown, Kevin E ^a   Ramsay, Mary ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ACUTE PANCREATITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDIDYMITIS; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MUMPS; ORCHITIS; OVARY INFLAMMATION; RISK REDUCTION; SEASONAL VARIATION; UNITED KINGDOM; VACCINATION; VIRUS MENINGITIS;

DISEASE OUTBREAKS; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MENINGITIS, VIRAL; MUMPS; ORCHITIS; PANCREATITIS; VACCINATION; WALES;

EID: 79953684873     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1704.101461     Document Type: Article

References (36)

1. Health Protection Agency. Mumps [cited 2010 Nov 8]. http:// www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Mumps/GeneralInformation
2. Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ. 2005;330:1132-5. DOI: 10.1136/bmj.330.7500.1132
3. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008;371:932- 44. DOI: 10.1016/S0140-6736(08)60419-5
4. Plotkin SA, Orenstein WA. Mumps vaccine. In: Plotkin SA, Orenstein WA, Offi t PA, editors. Vaccines. Philadelphia: Saunders; 2003.
5. Mumps virus vaccines. Wkly Epidemiol Rec. 2007;82:51-60.
6. National Health Service Information Centre. NHS immunization statistics, England, 2009-10 [cited 2011 Jan 1]. http://www.ic.nhs.uk/ statistics-and-data-collections/health-and-lifestyles/immunisation/ nhs-immunisation-statistics-england-2009-10
7. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13:12-7.
8. Savage E, Ramsay M, White J, Beard S, Lawson H, Hunjan R, et al. Mumps outbreaks across England and Wales in 2004: observational study. BMJ. 2005;330:1119-20. DOI: 10.1136/bmj.330.7500.1119
9. Yung C, Bukasa A, Brown K, Pebody R. Public health advice based on routine mumps surveillance in England and Wales. Euro Surveill. 2010;15:pii:19669.
10. Laboratory confi rmed cases of measles, mumps and rubella in England and Wales: January to March 2003. Commun Dis Rep Wkly. 2003 Jun 26 [cited 2011 Jan 1]. http://www.hpa.org.uk/cdr/ archives/2003/cdr2603.pdf
11. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358:1580-9. DOI: 10.1056/NEJMoa0706589
12. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine. 2008;26:3601-7. DOI: 10.1016/j.vaccine.2008.04.075
13. Centers for Disease Control and Prevention. Update: Mumps outbreak- New York and New Jersey, June 2009-January 2010. MMWR Morb Mortal Wkly Rep. 2010;59:125-9.
14. Boxall N, Kubinyiova M, Prikazsky V, Benes C, Castkova J. An increase in the number of mumps cases in the Czech Republic, 2005- 2006. Euro Surveill. 2008;13:18842.
15. Schaffzin JK, Pollock L, Schulte C, Henry K, Dayan G, Blog D, et al. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics. 2007;120:e862-8. DOI: 10.1542/ peds.2006-3451
16. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis. 2008;47:1458-67. DOI: 10.1086/591196
17. LeBaron CW, Forghani B, Beck C, Brown C, Bi D, Cossen C, et al. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis. 2009;199:552-60. DOI: 10.1086/596207
18. Barskey AE, Glasser JW, Lebaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine. 2009;27:6186-95. DOI: 10.1016/j.vaccine.2009.06.109
19. World Health Organization. International classifi cation of diseases (ICD), 10th edition [cited 2010 Nov 8]. http://www.who.int/ classifi cations/icd/en
20. Health and Social Information Centre. Hospital Episode Statistics (HES) online [cited 2010 Nov 8]. http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937
21. Philip RN, Reinhard KR, Lackman DB. Observations on a mumps epidemic in a "virgin" population. Am J Epidemiol. 1995;142:233- 53.
22. Barták V. Sperm count, morphology and motility after unilateral mumps orchitis. J Reprod Fertil. 1973;32:491-4. DOI: 10.1530/ jrf.0.0320491
23. Beard CM, Benson RC Jr, Kelalis PP, Elveback LR, Kurland LT. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clin Proc. 1977;52:3-7.
24. Falk WA, Buchan K, Dow M, Garson JZ, Hill E, Nosal M, et al. The epidemiology of mumps in southern Alberta 1980-1982. Am J Epidemiol. 1989;130:736-49.
25. Bjorvatn B, Skoldenberg B. Mumps and its complications in Stockholm. BMJ. 1978;1:788. DOI: 10.1136/bmj.1.6115.788-a
26. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, et al. Long-term persistence of mumps antibody after receipt of 2 measles- mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis. 2008;197:1662-8. DOI: 10.1086/588197
27. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics. 1993;91:17-22.
28. Henle G, Henle W. Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med. 1948;88:223-32. DOI: 10.1084/jem.88.2.223
29. Bitsko RH, Cortese MM, Dayan GH, Rota PA, Lowe L, Iversen SC, et al. Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol. 2008;46:1101-3. DOI: 10.1128/ JCM.01803-07
30. Yoshida N, Fujino M, Miyata A, Nagai T, Kamada M, Sakiyama H, et al. Mumps virus reinfection is not a rare event confi rmed by reverse transcription loop-mediated isothermal amplifi cation. J Med Virol. 2008;80:517-23. DOI: 10.1002/jmv.21106
31. Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46:1172-80. DOI: 10.1086/529141
32. Masarani M, Wazait H, Dinneen M. Mumps orchitis. J R Soc Med. 2006;99:573-5. DOI: 10.1258/jrsm.99.11.573
33. Werner CA. Mumps orchitis and testicular atrophy; a factor in male sterility. Ann Intern Med. 1950;32:1075-86.
34. Lane TM, Hines J. The management of mumps orchitis. BJU Int. 2006;97:1-2. DOI: 10.1111/j.1464-410X.2006.05869.x
35. Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev. 2001;65:208-31. DOI: 10.1128/MMBR.65.2.208-231.2001
36. Wharton IP, Chaudhry AH, French ME. A case of mumps epididymitis. Lancet. 2006;367:702. DOI: 10.1016/S0140-6736(06) 68274-3